Hospitalization costs of treating colorectal cancer in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hospitalization costs of treating colorectal cancer in China

Published:2019-08 Issue:33 Volume:98 Page:e16718
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Yuan Gao-Le,Liang Li-Zhong,Zhang Zhong-Fang,Liang Qi-Lian,Huang Zhen-Yi,Zhang Hui-Jie,Cheng Shao-Ang,Peng Xiao-Xia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference16 articles.

1. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study;Arié Figer;Cancer,2007

2. Epidemiology, disease progression, and economic burden of colorectal cancer;3Rd;J Manag Care Pharm,2007

3. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

4. Influencing factor analysis on hospitalization costs of 3046 cases with colorectal cancer on basic medical insurance in Beijing;Xiaoqiang;World Sci Technol,2011

5. Does increasing insurance improve outcomes for US cancer patients?;Smith;J Surg Res,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction and the influencing factor study of colorectal cancer hospitalization costs in China based on machine learning-random forest and support vector regression: a retrospective study;Frontiers in Public Health;2024-02-08

2. Estimating the economic burden of colorectal cancer in China, 2019–2030: A population‐level prevalence‐based analysis;Cancer Medicine;2023-12-19

3. Hospital Spending for Cancers in Hunan, China during 2017 and 2019;2023-10-30

4. Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system;BMC Health Services Research;2023-10-11

5. Cost Drivers and Financial Burden for Cancer-Affected Families in China: A Systematic Review;Current Oncology;2023-08-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3